Statement: the types of adverse events reported in the secondary trial are completely different from those in the primary trial
Primary_evidence: Adverse Events 1:   Total: 0/23 (0.00%)
Secondary_evidence: Adverse Events 1:   Total: 0/655 (0.00%) Adverse Events 2:   Total: 0/580 (0.00%)